罕见，百亿大佬操纵股价，被判三年

Core Viewpoint - The announcement from Meihua Biological indicates that its controlling shareholder, Meng Qingshan, has been sentenced to three years in prison (suspended for five years) for manipulating the securities market, which raises concerns about corporate governance and potential impacts on the company’s reputation and operations [1][2]. Group 1: Legal Proceedings and Sentencing - Meng Qingshan was prosecuted in March 2025 and received a criminal judgment from the Langfang Intermediate People's Court for manipulating the securities market [2]. - The court's decision includes a three-year prison sentence, suspended for five years, along with a fine [2]. - Meng Qingshan has not held any position in the company since his retirement in January 2017 and only exercises shareholder rights at shareholder meetings [2]. Group 2: Market Manipulation Details - The China Securities Regulatory Commission (CSRC) identified that Meng Qingshan and another individual manipulated Meihua Biological's stock price by controlling information release and trading activities [3][4]. - From July 8 to August 12, 2015, the stock price of Meihua Biological rose from 6.03 yuan to 10.34 yuan, an increase of 71.48%, significantly outpacing the Shanghai Composite Index's increase of 10.81% during the same period [3]. - The manipulation involved delaying the release of negative information while selectively disclosing positive news, which misled investors and inflated stock prices [5][6]. Group 3: Financial Penalties and Illegal Gains - The CSRC ordered the confiscation of illegal gains amounting to 56.5888 million yuan from Meng Qingshan and the other individual involved [6]. - A total fine of 170 million yuan was imposed, with Meng Qingshan responsible for 92 million yuan and the other individual for 78 million yuan [6]. - The actions of Meng Qingshan and the other individual were deemed to have a significant negative impact on investor expectations and market integrity [5][6].